Enzymatica Balance Sheet Health
Financial Health criteria checks 5/6
Enzymatica has a total shareholder equity of SEK76.6M and total debt of SEK26.1M, which brings its debt-to-equity ratio to 34.1%. Its total assets and total liabilities are SEK125.9M and SEK49.3M respectively.
Key information
34.1%
Debt to equity ratio
kr26.10m
Debt
| Interest coverage ratio | n/a |
| Cash | kr8.37m |
| Equity | kr76.61m |
| Total liabilities | kr49.30m |
| Total assets | kr125.91m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ENZY BTA's short term assets (SEK38.8M) exceed its short term liabilities (SEK24.4M).
Long Term Liabilities: ENZY BTA's short term assets (SEK38.8M) exceed its long term liabilities (SEK24.9M).
Debt to Equity History and Analysis
Debt Level: ENZY BTA's net debt to equity ratio (23.2%) is considered satisfactory.
Reducing Debt: ENZY BTA's debt to equity ratio has increased from 3.5% to 34.1% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ENZY BTA has sufficient cash runway for 2 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: ENZY BTA is forecast to have sufficient cash runway for 5 months based on free cash flow estimates, but has since raised additional capital.